Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
Author
dc.contributor.author
Arab, Juan P.
Author
dc.contributor.author
Roblero Cum, Juan
Author
dc.contributor.author
Altamirano, Jose
Author
dc.contributor.author
Bessone, Fernando
Author
dc.contributor.author
Chaves Araujo, Roberta
Author
dc.contributor.author
Higuera-De la Tijera, Fatima
Author
dc.contributor.author
Restrepo, Juan Carlos
Author
dc.contributor.author
Torre, Aldo
Author
dc.contributor.author
Urzúa Manchego, Álvaro
Author
dc.contributor.author
Simonetto, Douglas A.
Author
dc.contributor.author
Abraldes, Juan G.
Author
dc.contributor.author
Méndez-Sánchez, Nahum
Author
dc.contributor.author
Contreras, Fernando
Author
dc.contributor.author
Lucey,
Admission date
dc.date.accessioned
2019-10-30T15:22:20Z
Available date
dc.date.available
2019-10-30T15:22:20Z
Publication date
dc.date.issued
2019
Cita de ítem
dc.identifier.citation
Annals of Hepatology, Volumen 18, Issue 3, 2019, Pages 518-535
Identifier
dc.identifier.issn
16652681
Identifier
dc.identifier.other
10.1016/j.aohep.2019.04.005
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/172229
Abstract
dc.description.abstract
Alcohol-related liver disease (ALD) is a major cause of advanced chronic liver disease in Latin-America, although data on prevalence is limited. Public health policies aimed at reducing the alarming prevalence of alcohol use disorder in Latin-America should be implemented. ALD comprises a clinical-pathological spectrum that ranges from steatosis, steatohepatitis to advanced forms such as alcoholic hepatitis (AH), cirrhosis and hepatocellular carcinoma. Besides genetic factors, the amount of alcohol consumption is the most important risk factor for the development of ALD. Continuous consumption of more than 3 standard drinks per day in men and more than 2 drinks per day in women increases the risk of developing liver disease. The pathogenesis of ALD is only partially understood and recent translational studies have identified novel therapeutic targets. Early forms of ALD are often missed and most clinical attention is focused on AH, which is defined as an abrupt onset of jaundice and liver-related complications. In patients with potential confounding factors, a transjugular biopsy is recommended. The standard therapy for AH (i.e. prednisolone) has not evolved in the last decades yet promising new therapies (i.e. G-CSF, N-acetylcysteine) have been recently proposed. In both patients with early and severe ALD, prolonged abstinence is the most efficient therapeutic measure to decrease long-term morbidity and mortality. A multidisciplinary team including alcohol addiction specialists is recommended to manage patients with ALD. Liver transplantation should be considered in the management of patients with end-stage ALD that do not recover despite abstinence. In selected cases, increasing number of centers are proposing early transplantation for patients with severe AH not responding to medical therapy.
Alvear A, Jorge; Andreani, Silvia; Cortés M, Fanny(1998)
Background: Fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE) encompass a pattern of birth defects in persons whose mothers ingested alcohol during pregnancy. People with FAE display fewer of the FAS traits. ...
Objective: To assess the relationship between early tobacco and alcohol use and the risk of marijuana consumption among schoolchildren. Methods: A cross-sectional study comprising data from the Fourth National Study on ...